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Main results: Intraperitoneal implantation of purified 
beta-cells improved the diabetic state within 8-10 days. 
The metabolic parameters were stable within 4-5 weeks 
after islet transplantation in fifteen of twenty-one 
recipients (71.4%). Stimulation with PHA at 21 days 
post beta- cells grafts produced a marked increase in 3H- 
Thymidine incorporation in lamina propria and Peyer’s 
patches lymphoid T cells. 
Conclusions: (1) These results demonstrated normal- 
ization of metabolic and immunologic parameters 
in diabetic rats which received associated therapy 
(pancreatic beta-cells and E. coli vaccine) and (2) beta- 
cells stimulated the immune response to Escherichia coli 
vaccine. 
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Allogeneic stem cell transplantation from donors other 
than HLA-matched siblings results in a high risk of post- 
transplant infections because of the risk of graft-versus- 
host disease (GVHD) with an unmanipulated graft, or 
delayed immune reconstitution following T cell-depletion 
(TCD). We compared infectious outcomes in the first 
yr post-transplant (tx) in 28 consecutive recipients of 
stringently TCD blood hematopoeitic progenitor cell 
(HPC) grafts from haploidentical family donors (HD), 
and 28 consecutive recipients of unmanipulated grafts 
from matched or 1 Ag mismatched unrelated donors 
(URD). Included are pts (excluding CML-CPl) trans- 
planted at our center between 6198 and 12/01 after 
myeloablative conditioning. HD pts received pre-tx ATG, 
and no scheduled post-tx immunosuppression. URD pts 
received tacrolimus and methotrexate for GVHD 
prophylaxis. Median CD3-t cell dose/kg was 3.6 logs 
lower in the HD vs URD grafts (p<O.OOOl). Median age 
was 31y (21-56) for HD and 43y (18-51) for URD pts. 
15 HD and 17 URD pts were in relapse at time of 
transplant. Acute and/or chronic extensive GVHD 
occurred in 80% of evaluable URD pts vs 15% of HD 
pts (p<O.OOl). Bacteremias were the most common in- 
fections, occurring at similar frequencies in the two groups. 
Polymicrobial bacteremias occurred exclusively in URD 
patients (n=7; p=O.O09). Proven/probable invasive 
fungal infections (IFI) occurred in 23% of HD pts, and 
12% of URD pts (p =NS). Frequency and timing of 
CMV reactivation (by PCR), late CMV reactivation (>d 
loo), and CMV disease were similar in the two groups. 
EBV-associated PTLD was unique to HD pts (n=3), 
and drug-resistant HSV disease was also more common 
after HD tx. Infection related deaths (censored at 1 yr) 
in HD pts included bacterial sepsis (3),Aspergillosis (3) 
parainfluenza pneumonia (2) PCP (1) other pneumonia 
(l), amebic encephalitis (1) toxoplasmosis (1) EBV- 
PTLD (l), and acalculous cholecystitis (1). Infectious 
deaths in URD pts resulted from IF1 (3) bacterial sepsis 
(2), CMV pneumonia (1) aspiration pneumonia (1) and 
acalculous cholecystitis (1). 
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Infections are the most common cause of death in these 
pts. The trend toward higher risk of infectious death 
following TCD HD vs unmanipulated URD transplants 
was not statistically significant, although the spectrum of 
infections was different. Strategies aimed at enhancing 
immune reconstitution without stimulating GVHD are 
needed to reduce the risks of infection and relapse after 
stringently TCD alternative donor transplantation. 
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The spectrum of Aspergillus induced human pulmonary 
afflictions vary greatly from apparently harmless 
colonization to a fulminant and rapidly fatal disease. 
Invasive aspergillosis (IA) is a disease that occurs 
primarily in severely immunocompromised patients, 
clinical diagnosis in whom is often difficult and missed, 
adding to the severity of the outcome. 
Aims and objectives: To study the occurrence of IA 
in cases of chronic bronchopulmonary disorders with 
locally and/ or systemically immunocompromised con- 
ditions and correlate the role of clinical and radiological 
parameters of these patients with a battery of laboratory 
investigations in the early diagnosis and management. 
Materials and methods: Thirty-four patients of chronic 
bronchopulmonary disorders with suspected aspergillosis 
and underlying immunocompromised state were studied. 
Thorough clinical, hematological and radiological exam- 
inations were carried out. Sputum, bronchial aspirate/ 
BAL and serum samples were collected. Microscopy and 
culture for Aspergillus spp in addition to detection of 
specific anti-A. fumigatus IgG and IgE by ELISA and 
skin sensitivity tests against Aspergillus spp were per- 
formed. 
Results: Out of 34 cases studied, 7 were diagnosed as IA: 
2 as highly probable and 5 as probable cases. IA was 
found to be most common in ~20 and ~60 years of age 
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with a male: female sex ratio of 2.5: 1. Fungal culture 
was positive in 85.71% whereas AEC was increased 
in 42.86% cases. Microscopic evidence and antibody 
response was detectable in only 2 cases each (28.57%). 
None of the cases showed a positive skin response. 
Conclusions: It is emphasized that in the light of a strong 
clinical suspicion, a rigorous laboratory work up in the 
form of microscopy, culture and immunological studies 
is warranted for an early diagnosis and management of 
IA in order to avoid serious and fatal complications. 
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Background: Paecilomyces lilacinus is a rare oppor- 
tunistic pathogen in man and due to in vitro resistance 
to amphotericin B treatment is extremely difficult. 
Successful therapy with ketoconazole, itraconazole, 
and terbinafine has been sporadically reported although 
optimal treatment for serious infections due to I? lilacinus 
remains uncertain. 
Results: A cluster of red nodules developed in a 64-year- 
old diabetic woman with metastatic adenocarcinoma of 
the pancreas. In the following two weeks, an extensive 
area involving the right lower leg and isolated cluster of 
lesion in the medial mid-thigh were noticed. Six months 
earlier, she had received weekly gemcitabine (1000 
mg/m”). She also underwent multiple hospitalizations 
for severe asthma exacerbation requiring high-dose 
corticosteroides in the preceding three months. Extensive, 
excoriated nodules and pustules overlying erythematous 
and indurated base were present on examination of the 
right lower extremity. WBC 10.8 x lO?uL, creatinine 3.3 
mg/ml, LDH 389 U/L, AST 46 U/L, and ESR 16 mm/h. 
Blood cultures were sterile. No acute pulmonary process 
was seen on chest computed tomography scan. Within 
three days, prominent growth (5 to 10 colonies) of 
Paecilomyces lilacinus was isolated from several skin 
lesions. The in vitro antifungal susceptibility was deter- 
mined at two intervals (MIC (g/ml; 48 h and 72 h) 
and are as follows: amphotericin B 16.0 and 16.0, 
ketoconazole 1.0 and 1.0, itraconazole 1.0 and 4.0, 
voriconazole 0.25 and 0.25, posaconazole 0.125 and 
0.125, ravuconazole 0.5 and 1.0, and caspofungin 1.0 and 
4.0. Treatment with oral itraconazole 600 mg daily (for 
3 days) than 400 mg daily was initiated. Seven days later, 
caspofungin 70 mg, than 50 mg daily was added due to 
lack of clinical response. In the following week, 
excoriated nodules involving the mid-thigh, and lower 
leg resolved. No new pustules were noticed. Treatment 
was continued for four weeks, with complete resolution 
of the P lilacinus infection, and there were no significant 
side effects of the therapy. 
Conclusions: Since 1977, less than 25 cases of cutaneous 
Paecilomyces infection have been reported. Suscepti- 
bility to amphotericin B, flucytosine, triazole-based 
agents is variable and P lilacinus frequently shows in 
vitro resistance to the currently available agents. The in 
vitro susceptibility profiles of the newer, broad-spectrum 
triazoles appears to be promising, and treatment with 
combination antifungals in my patient lead to rapid 
clearing of infection. 
Prospective evaluation of candida colonization and 
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Background: Most invasive Candida infection arises 
from hosts’ endogenous flora, and critically ill patients 
with prominent Candida colonization are considered at 
risk for near-future systemic invasion. This association in 
non-critically ill adults with cancer is unclear. 
Methods: During July 11998 to April 14 1999,193 patients 
with prominent colonization (~50 Candida colonies 
from nonsterile source) were evaluated prospectively, 
and followed for 14 weeks after the initial cultures. 
Results: Solid-organ cancer was most common (129) 
Cancer, 43 had hematological malignancies, and 17 
underwent allogeneic marrow graft transplantation. Six 
had AIDS, and 13 with benign conditions. Fifty-three 
(27.5%) patients expired, of these 25 (19.4%) had solid- 
organ cancer, 60.5% with hematological malignancy. 
Eleven (65%) marrow transplantation recipients died. 
No deaths were observed in patients with AIDS, and one 
in those with benign diseases. Among 53 that died, 26 
(49%) had respiratory tract colonization, 13 (24.5%) GI 
tract and 3 (5.7%) GU tract. Fifty percent with 22 body 
site colonization expired and all 4 patients (100%) with 
two respiratory tract sites died. Twenty-one percent died 
with a single site C. albicans colonization, and 53.8% 
with ~2 sites involved, similarly for C. glabrata 46.7% 
with single site, and 100% with multiple sites. Single site 
colonization and mortality was highest for C. krusei 
(75%), while in case of C. tropicalis (30%) and C. 
parapsilosis (25%) it was substantially lower. Four 
patients (18.2%) among those with r2 Candida species 
colonization expired, 100% mortality in patients with C. 
albicans+ C, krusei dual species colonization, while 20% 
in 10 patients with C. albicans+C. glabrata. NO short- 
term mortality was seen in patients with C. albicans + C. 
